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Objectives: Campylobacter jejuni has been classified as a member of priority pathogens 25 
group due to the rapid emergence of multidrug resistant isolates. In the present study we 26 
planned to determine the prevalence, antibiotic resistance patterns and source tracking of 27 
clinical C. jejuni isolates from pediatric diarrheal patients in Pakistan.  28 
Methods: A total of 150 stool samples from children were processed for the presence of 29 
Campylobacter jejuni using culture, biochemical tests and by species spcific PCR. 30 
Antibiotic susceptibility of the isolates was determined by disc diffusion method and 31 
metallo-beta-lactamase (MBL) producers were detected using gene specific PCR. Source 32 
tracking was done using source predictive PCR. 33 
Results: Campylobacter jejuni was present in 54.6% of the processed samples. More34 
than 80% of the isolated strains were resistant to 7 out of 12 antibiotics tested. High level 35 
of susceptibility was observed against imipenem (12.2%) and tigecycline (9.7%).  Six 36 
isolates (7.3%) were metallo-beta-lactamase producers and were positive for at least one 37 
of the five metallo-beta-lactamase genes. Source tracking showed that 57.3% of the 38 
isolates belonged to livestock associated cluster (C1 to C6) and 42.8% were assigned to 39 
non-livestock /environmental clusters (C7-C9). Isolates belonging to livestock cluster had 40 
high Multiple Antibiotic Resistance (MAR) index (p value<0.001) as compared to non-41 
livestock. 42 
Conclusion: High prevalence of multidrug resistant C. jejuni among pediatric diarrheal 43 
patients was observed. Moreover, association of these isolates to livestock clades suggest 44 
transmission to human population via food chain and presence of imipenem resistant 45 
MBL producing C. jejuni can lead to serious public health concerns. 46 
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 49 
1. Introduction 50 
Diarrhea, despite being preventable and treatable, is still the second leading cause of 51 
mortality among children less than five years of age, worldwide [1]. Diarrheal illness can 52 
be caused by both viral and bacterial infections. Campylobacter jejuni has been listed as 53 
one of the most frequent bacterial cause of diarrhe in recent years [2,3]. C. jejuni is a 54 
foodborne pathogen that is transmitted to humans via handling or consumption of 55 
undercooked meat (poultry, cattle and pigs), raw milk and untreated water [4,5].  56 
Campylobacteriosis is generally a self-limiting disea e but antibiotics like macrolides 57 
(azithromycin and erythromycin) and fluoroquinolones (ciprofloxacin) are recommended 58 
in some cases, for instance in treatment of  immunocompromised patients [6,7]. Over the 59 
past two decades the emergence of multidrug resistant C. jejuni especially against 60 
erythromycin, fluoroquinolones and tetracycline have been reported from both 61 
developing and developed countries [7,8]. C. jejuni, being a zoonotic pathogen acquires 62 
antimicrobial resistance mainly through use of these antibiotics as prophylaxis in animal 63 
farming [9, 10,11]. Disproportionate use of antibiotics in livestock industry results in 64 
development of more resistant isolates either by the introduction of mutations or 65 
acquisition of antibiotic resistance genes through horizontal gene transfer from other 66 
bacteria [12,13]. Nevertheless, sources other than livestock such as wild birds and pets 67 
have been recently reported to contribute to the campylobacteriosis burden [10,14,15]. 68 
Over the past years many outbreaks of campylobacteriosis have been reported due to 69 













consumption of water contaminated with domestic and wil  animal fecal material as well 70 
as sewage discharge [4, 16, 17, 18]. Source attribution can not only help to identify the 71 
origin of C. jejuni infection but also help solve the puzzle by linking extremely drug 72 
resistant pathogens circulating in human populations especially among vulnerable 73 
children to infection source. Genotyping of C. jejuni isolates by MLST has been 74 
commonly employed for the clonal clustering of strains on the basis of potential source; 75 
however, it does not take into account genetics adapt tion to specific environment/niche. 76 
A source predictive Multiplex PCR, based on adaptive genotypes identified by 77 
microarray analysis, has been developed by Stabler et al. (2013) to cluster C. jejuni 78 
isolates into livestock and non-livestock groups [19, 20, 21, 22, 23]. This source 79 
predictive PCR method has been shown earlier to provide comparable results in source 80 
tracking of human isolates to MLST [19]. In developing countries like Pakistan, this 81 
source predictive PCR method provides a reliable and cheap alternate for genotyping of 82 
human isolates to predict their origin [30]. The prsent study was aimed to investigate the 83 
prevalence and antibiotic resistance profile of C. jejuni among paediatric diarrheal 84 
patients; possible linkage of human infections to livestock or non-livestock sources 85 
(water and wildlife) using source predictive markers and linking antibiotic resistance 86 
potential of the isolates to a particular source.  87 
 88 
2. Materials and Methods 89 
2.1 Sampling Collection and Identification of Campylobacter jejuni 90 
A total of one hundred and fifty human diarrheal stool samples (including both non-91 
bloody and bloody diarrheal cases) were collected from hospitalized pediatric patients 92 













from December 2014 - September 2015. Samples were collected from hospitals of major 93 
cities of Pakistan (Supplementary table 1). Children’s age varied from 2 months to 5 94 
years. All the cases were domestic in origin. The samples were streaked onto modified 95 
charcoal cefoperazone deoxycho-late agar (mCCDA) (Oxoid, Basingstoke, UK) and 96 
incubated for 48-72 hrs at 42°C under microaerophilic conditions. Preliminary 97 
identification of Campylobacter jejuni colonies was performed by biochemical tests 98 
including oxidase, catalase, indoxyl acetate and hippurate hydrolysis. PCR based 99 
detection was done using primers specific for hipO gene (hippurate hydrolysis gene) [24]. 100 
(supplementary table 2) 101 
2.2 Antimicrobial Resistance profiling 102 
Antibiotic resistance profiling of the identified C. jejuni isolates was carried out using the 103 
following antibiotics: ceftriaxone (CTX)(30 µg) (Oxoid, UK), ampicillin (AMP)(10 µg) 104 
(Oxoid, UK), chloramphenicol (C)(30 µg) (Oxoid, UK), tetracycline (TE) (30 µg) 105 
(Oxoid, UK), streptomycin (S) (10 µg) (Oxoid, UK), ciprofloxacin (CIP) (5 µg) (Oxoid, 106 
UK), nalidixic acid (NA) (30 µg) (Oxoid, UK), erythromycin (E) (30 µg) (Oxoid, UK), 107 
gentamycin (CN) (10 µg) (Oxoid, UK), sulphomethoxazole + trimethoprim (SXT) (25 108 
µg) (Oxoid, UK), tigecycline (TGC)(15 µg) (Oxoid, UK) andimipenem (IMP) (10 µg) 109 
(Oxoid, UK) [25, 26]. This panel of antibiotics was chosen in accordance with Clinical & 110 
Laboratory Standards Institute (CLSI) guidelines and previously reported emerging 111 
resistance reports inC. jejuni [25]. Analysis of zone diameter for resistance profiling of 112 
erythromycin, ciprofloxacin, tetracycline, ampicillin and nalidixic acid was done 113 
according to the Clinical & Laboratory Standards Intitute (CLSI) (2016) for 114 
Campylobacter and rest of the antibiotics guidelines for enterobacteriaceae were used. 115 













Multiple antibiotic resistance (MAR) was calculated by using the formula a/b where ‘a’ is 116 
the number of antibiotics to which a isolate is resistant and ‘b’ is the total number of 117 
antibiotics tested [27]. 118 
2.3 Detection of Metallo-β-lactamase   119 
Phenotypic identification of MBL enzyme in imipenem resistant isolates was performed 120 
using the combined disk method (CDT) [28]. Briefly, overnight cultures of the test strains 121 
were exposed to one imipenem and another imipenem disk amended with ethylene 122 
diamine tetra-acetic acid (EDTA) placed 25 mm apart on Muller Hinton agar plates. An 123 
increase of ≥7 mm in the diameter of the imipenem inhibitory zone compared to 124 
imipenem-EDTA disk after 24 hours of incubation confirmed presence of metallo-β-125 
lactamase positive organism. To verify the presence MBL genes at molecular level a 126 
multiplex PCR was used. Five primer pairs, specific for each family of acquired MBLs, 127 
were used for the detection of blaIMP, blaVIM , blaSPM, blaGIM and blaSIM genes [29]. The 128 
primers and amplification conditions used are listed in supplementary table 2. 129 
2.4 Source Attribution  130 
To predict the possible origin of C. jejuni in human samples source predictive markers 131 
were used as described by Stabler et al., [21]. Six source discriminatory genes i.e., 132 
Cj0056c (hypothetical protein), Cj0485 (putative oxidoreductase), Cj1139c (beta- 1,3 133 
galactosyltransferase), Cj1324 (hypothetical protein) Cj1422c (putative sugar 134 
transferase), and Cj1720 (hypothetical protein) were amplified in two sets of multiplex 135 
PCRs (M1 and M2). The strain Cj255 from chicken was used as a positive control with 136 
all target genes present, and nuclease free water with no DNA template was used as a 137 
negative control [30]. Primers and the thermal amplification condition used in the two 138 













multiplex PCRs are mentioned in supplementary table 2. The results of PCR were 139 
converted into binary data (based on presence or absence of amplified product) and 140 
analyzed according to the binary code provided by Stabler et al. [21].  Dendrogram based 141 
on this binary data was constructed using PAST3.16 Software [31]. 142 
2.5 Statistical analysis 143 
Statistical analysis was performed using the Student's t-test. Data were considered 144 
significant at a p value of ≤0.05 145 
 146 
3. Results and Discussion 147 
Diarrhoeal disease, world-wide, ranks as the fourth most frequent cause of death. The 148 
estimated diarrheol related disability-adjusted life-years (DALYs) burden is 149 
underestimated due inconsideration of the long-term sequelae as a consequence of 150 
undernutrition, increased risk of infectious disease nd increased prevalence of protein 151 
energy malnutrition associated with the disease in ch ldren under 5[32] . While the 152 
disease affects most of the worlds population, more than half of the total number of 153 
reported cases and 80% of the child mortalities occur in South Asia and Africa [2].  154 
Campylobacter jejuni has been classified by WHO as “High priority pathogens” due to 155 
emergence of multidrug resistance. Therefore, routine surveillance is necessary for the 156 
control of disease.  The prevalence of multidrug resistant isolates of C. jejuni has been 157 
under reported in developing countries like Pakistan, compared to developed countries, 158 
due to lack of proper surveillance programs. In the pr sent study  the prevalence of 159 
multidrug resistant C. jejuni,  and their sources of transmission  in  human clinical cases 160 
was investigated . A total of 150 stool samples from children suffering from diarrhea, 161 













predominantly belonging to low income group (LIG), were collected and cultured on 162 
mCCDA agar (Supplementary table 1). Biochemically identified C. jejuni strains were 163 
further confirmed by PCR using primers against the hipO gene (hippurate hydrolysis 164 
gene). C.  jejuni was found to be present in 82 samples indicating a relatively high 165 
isolation rate of 54.6% compared to previous reportsfrom Pakistan indicating11.3-29.5% 166 
prevalence rates during the years 1993-2013 [26, 32, 3 , 34]. This increase in prevalence 167 
of C. jejuni could be attributed to many reasons including the increase in antibiotic 168 
resistant strains in the population in the past few y ars. To validate this hypothesis, we 169 
compared the antibiotic resistance profile of C. jejuni to that of previously reported 170 
isolates from our laboratory in year 2011-2012 [26]. 171 
Antibiotic susceptibility testing of the isolates showed that most of the isolates, ranging 172 
from 9.8-98% were resistant to tested antibiotics.. More than 80% of the isolates were 173 
found to be resistant to the following antibiotics: ampicillin (98%), erythromycin (98%), 174 
streptomycin (94%) and tetracycline (89%), trimethoprim/sulfamethoxazole (88%), 175 
cefotaxime (83%), gentamycin (80%), nalidixic acid (82%), ciprofloxacin (73%). 176 
Whereas, a moderate percentage of isolates were resistant to chloramphenicol (40%) . 177 
Isolates were more sensitive to imipenem (12% resistant) and tigecycline (9% resistant). 178 
Overall 75% of isolates were resistant to more than eight of the tested antibiotics. 179 
Comparison of resistance profiles of C. jejuni isolates from 2011-2012 indicated an 180 
increased rate of resistance to all the tested antibiotics. The percentage of resistant 181 
isolates to ampicillin increased from 40% to 98%, streptomycin from 53% to 94%, 182 
ciprofloxacin 20% to 73%, erythromycin 27% to 98%, tetracycline 27% to 89%, 183 
sulphomethoxazole + trimethoprin 40% to 88%, gentamycin from 7% to 80%, 184 













chloramphenicol 20% to 40% and nalidixic acid 13% to 82% [26]. Poultry related C. 185 
jejuni isolates have earlier been reported to show higher resistance to antibiotics due to 186 
their indiscriminate use as a growth promoter such as streptomycin and erythromycin in 187 
the feed which may lead to cross transmission in humans [35, 36]. The high resistance 188 
profile observed in this study is similar to those reported in poultry isolates previously, 189 
compared to clinical isolates, suggesting the possible transmission from poultry to 190 
humans [26, 37, 38, 39].  191 
Antibiotics belonging to the class β-lactams have been used a  first line of therapy due to 192 
their high efficacy and low toxicity to humans. The choice of β-lactams is reduced to 193 
carbapenems when infections are caused by extended-spectrum β-lactamase (ESBL) 194 
producing organisms. Such ESBL producing isolates have also been reported in C. jejuni 195 
but studies so far have not reported any resistance to arbapenem. In the present study 10 196 
C. jejuni isolates were found to show resistance to imipenem (member of carbapenem 197 
family) by the disc diffusion method.   MBL enzyme d tection through CDT showed that 198 
10% (n=8) of the isolates were MBL positive. PCR amplification of blaIMP, blaVIM , 199 
blaSPM, blaGIM and blaSIM ,  genes showed that 7.3% (n=6) of isolates were positive for 200 
MBL genes. Three isolates carried both blaIMP and blaVIM  genes, three isolates carried 201 
either blaVIM , blaIMP or blaSIM gene. None of the isolates were positive for GIM or SPM 202 
(Fig. 1). Two isolates out of 8 that showed phenotypic MBL production were PCR 203 
negative for the screened MBL genes. This is the first report on emergence of imipenem 204 
resistant isolates among C. jejuni in clinical samples and hence may affect the treatm n  205 
and subsequent recovery among patients (Table 1).    206 













In order to determine the source of transmission of resistant strains, all the C. jejuni 207 
isolates were assigned to strain clusters using the binary code based on the presence or 208 
absence of amplified products of six source predictive genes sequences (Fig. 2,3A). The 209 
results showed that isolates were well distributed among all groups i.e., C1/C2/C3 210 
(14.6%), C4/C6 (26.8%), C5 (15.8%), C7/C8 (24.3%) and C9 (18.2%). Overall 57.3% of 211 
the isolates belonged to C1 to C6 clusters which have been previously described as 212 
livestock-associated (Fig. 4B) whereas 42.8% of isolates belonged to C7 to C9 clusters 213 
predicted to be of non-livestock /environmental origin [20,21]. The relationship of 214 
livestock and non-livestock associated strains along with MAR Index is shown in 215 
phenogram [31] (Fig. 2). The MAR index is a health risk assessment tool which coupled 216 
with source prediction may be used to determine origin of antibiotic resistant strains 217 
which may be linked to sources exposed to high antibiotic use. High values indicate 218 
‘higher-risk’ source of isolate [40]. Interestingly, in the present study isolates belonging 219 
to livestock cluster had high MAR index (p<0.001) compared to non-livestock suggesting 220 
presence of more multidrug resistance among isolates of livestock origin (Fig. 4B, 4C).  221 
Excessive use of antibiotics in livestock industry exerts a selective pressure on bacterial 222 
pathogens resulting in development of more resistant isolates by either mutation or 223 
acquisition of antibiotic resistance genes through horizontal gene transfer from other 224 
bacteria [12,13].  225 
Pakistan is a livestock raising country with approximately 180 million head of livestock 226 
and 1640 million of commercial poultry and a few millions of poultry in backyard 227 
practices. The poultry industry contributes 26.8% to total meat production in Pakistan. 228 
However, with current farming practices, use of antimicrobials to cure and prevent 229 













disease as well as promote growth have been extensive leading to a rise in multi-drug 230 
resistance in associated microbiota including C. jejuni. The association of more resistant 231 
C. jejuni to livestock clades in the present study depicts the ability for such strains to 232 
persist and spread, through the food chain, from ani ls to humans.. High prevalence of 233 
antibiotic resistance and linkage of isolates, with high MAR index, to livestock clade 234 
observed in the present study provide evidence of possible transmission of C. jejuni from 235 
animals to human, thus posing serious health concern.   236 
 237 
4. Conclusion 238 
In the present study, a high prevalence of C. jejuni among paediatric diarrheal patients 239 
were recorded which were linked to both livestock and non-agricultural/non-240 
domesticated sources. Association of significant number of isolates with high MAR with 241 
livestock indicate possible selection and transmission of these isolates from animals to 242 
humans, thus stressing the need to the control of the indiscriminate use of antimicrobials 243 
in animal farming. 244 
245 
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Table 1: Detail of imipenem resistant C. jejuni strains. 410 













BH14 R (11) + blaIMP , 
blaVIM  
0.75 C1/C2/C3 
SH56 R (14) + blaIMP  0.83 C1/C2/C3 
PH14 R (16) + blaSIM  0.75 C7/C8 
PH2 R (15) + blaVIM  0.83 C5 
PH8 R (14) + blaIMP , 
blaVIM   
0.67 C5 
PH15 R (16) + blaIMP , 
blaVIM  
0.75 C1/C2/C3 
AS51 R (13) + - 0.75 C1/C2/C3 
PH29 R (17) - - 0.83 C4/C6 













SH58 R (15) + - 0.839 C4/C6 






Figure Legends 416 
Figure 1 Detection of metallo-b-lactamases in C. jejuni using multiplex PCR assay 417 
for MBL encoding genes i.e., blaIMP (188bp), blaSIM  (390bp), and 418 
blaVIM (570bp) 419 
Figure 2 Dendrogram displaying source attribution clusters of C. jejuni strains, 420 
based on binary data of PCR profiles by using UPGMA analysis 421 
(PAST3.16 Software); Green strain labels MAR=0.35-0. , Blue strain 422 
labels- MAR=0.5-0.75, Red strain labels=0.8-0.9; *** indicate isolates 423 
which are MBL producers. 424 
Figure 3  A) Source predictive multiplex PCR: lane 1, 100-bp ladder; lane 2, strain 425 
BH20 (mPCR 1); lane 3, strain BH20 (mPCR 2); lane 4, strain SH11 426 
(mPCR 1); lane 5, strain SH11 (mPCR 2). mPCR 1 involved amplification 427 
of genes Cj1422, Cj1139 and Cj0056. mPCR 2 involved amplification of 428 
genes Cj1324, Cj1720 and Cj0485. B) Percentage of isolates and average 429 
MAR index of isolates attributed to livestock and non-livestock clusters. 430 
C) Percentage of resistant isolates belong to livestock and non-livestock 431 













cluster to ceftriaxone (CTX), ampicillin (AMP), chloramphenicol C, 432 
tetracycline (TE), streptomycin (S), ciprofloxacin (CIP), nalidixic acid 433 
(NA), erythromycin (E), gentamycin (CN), sulphomethoxazole + 434 
trimethoprim (SXT), tigecycline (TGC), imipenem (IMP) 435 
 436 












• High prevalence of among diarrheal paediatric patients.  
• Majority of C. jejuni (>90%) isolates were multidrug resistant. 
• 7.3% of isolates were metallo-beta lactamase producers.  
• Livestock associated Isolates had high MAR index as compared to non-livestock. 



















Figure 1.  
 
 















































Figure 3.  
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